Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries

Corrado Barbui, Michela Nos??, Maria Angela Mazzi, Jonathan Bindman, Morven Leese, Aart Schene, Thomas Becker, Matthias C. Angermeyer, Maarten Koeter, Richard Gray, Michele Tansella
  • International Clinical Psychopharmacology, March 2006, Wolters Kluwer Health
  • DOI: 10.1097/01.yic.0000185022.48279.db
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Professor Richard John Gray